Published in J Thromb Haemost on December 11, 2009
Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood (2011) 2.24
Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost (2012) 1.71
Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood (2012) 1.46
Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation. Blood (2012) 1.14
Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities. Biochemistry (2010) 1.08
Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease. Front Physiol (2014) 1.01
Factor XI anion-binding sites are required for productive interactions with polyphosphate. J Thromb Haemost (2013) 0.90
Hageman factor, platelets and polyphosphates: early history and recent connection. J Thromb Haemost (2010) 0.88
Polyphosphate suppresses complement via the terminal pathway. Blood (2013) 0.85
Polyphosphate: a new player in the field of hemostasis. Curr Opin Hematol (2014) 0.85
Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation. J Thromb Haemost (2012) 0.79
Platelet polyphosphate: an endogenous activator of coagulation factor XII. J Thromb Haemost (2010) 0.79
Polyphosphate multi-tasks. J Thromb Haemost (2012) 0.78
Polyphosphate: a link between platelets, coagulation and inflammation. Int J Hematol (2012) 0.77
Positively-charged semi-tunnel is a structural and surface characteristic of polyphosphate-binding proteins: an in-silico study. PLoS One (2015) 0.75
Polyphosphate co-localizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity. Blood (2016) 0.75
Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci U S A (2006) 3.09
Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem (2004) 2.41
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Directing thrombin. Blood (2005) 1.85
A player of many parts: the spotlight falls on thrombin's structure. Thromb Res (1993) 1.64
Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost (2007) 1.61
Crystal structure of thrombin bound to heparin. J Biol Chem (2004) 1.61
Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci U S A (1994) 1.22
An extensive interaction interface between thrombin and factor V is required for factor V activation. J Biol Chem (2001) 1.20
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry (1993) 1.16
Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry (1990) 1.15
Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. J Biol Chem (1996) 1.11
Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. J Biol Chem (1994) 1.09
Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Proc Natl Acad Sci U S A (2003) 1.07
Characterization of proexosite I on prothrombin. J Biol Chem (2000) 1.06
Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively. J Biol Chem (2003) 1.00
Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. J Biol Chem (1999) 0.98
The affinity of protein C for the thrombin.thrombomodulin complex is determined in a primary way by active site-dependent interactions. J Biol Chem (2005) 0.96
Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem (1994) 0.96
Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate. J Biol Chem (2003) 0.95
Influence of Arginines 93, 97, and 101 of thrombin to its functional specificity. Biochemistry (1997) 0.94
Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes. J Biol Chem (1998) 0.93
Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin. J Biol Chem (1990) 0.93
Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. Biochemistry (2001) 0.92
Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin. J Biol Chem (1997) 0.92
Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. J Biol Chem (1994) 0.92
Crystallographic structure of human gamma-thrombin. J Biol Chem (1994) 0.91
Occupancy of anion binding exosite 2 on thrombin determines Ca2+ dependence of protein C activation. J Biol Chem (1994) 0.88
Preparation and use of polyphosphate-modified zirconia for purification of nucleic acids and proteins. Anal Biochem (1994) 0.87
Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J (1995) 0.81
Dissociation of thrombin's substrate interactions using site-directed mutagenesis. Trends Cardiovasc Med (2000) 0.78
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest (1996) 2.51
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
POLYCYSTIC KIDNEY. Ann Surg (1926) 2.38
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem (1991) 1.67
Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost (2007) 1.67
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response. Crit Care Med (2001) 1.61
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol (1989) 1.61
Gram stain method shows better sensitivity than clinical criteria for detection of bacterial vaginosis in surveillance of pregnant, low-income women in a clinical setting. Infect Dis Obstet Gynecol (1998) 1.57
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell (1992) 1.48
Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol (1989) 1.48
Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry (1995) 1.47
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Properties of recombinant human thromboplastin that determine the International Sensitivity Index (ISI). J Thromb Haemost (2004) 1.46
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A (1988) 1.44
Rapid and efficient incorporation of tissue factor into liposomes. J Thromb Haemost (2004) 1.40
Detection of choroid plexus carcinoma with Tc-99m sestamibi: case report and review of the literature. Med Pediatr Oncol (2001) 1.40
Polyphosphate as a general procoagulant agent. J Thromb Haemost (2008) 1.36
Functional expression of human PP2Ac in yeast permits the identification of novel C-terminal and dominant-negative mutant forms. J Biol Chem (1999) 1.35
Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell (1999) 1.35
Management of acute subdural hematomas from aneurysmal rupture. Can J Neurol Sci (1984) 1.33
Differential synthesis of spore coat proteins in prespore and prestalk cells of Dictyostelium. Proc Natl Acad Sci U S A (1982) 1.32
Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem (1994) 1.30
Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem (1992) 1.27
Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation (1995) 1.25
Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Expr Purif (1992) 1.24
Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem (1993) 1.11
Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain. A fluorescence resonance energy transfer study. J Biol Chem (1997) 1.10
Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation (2000) 1.10
Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A (1990) 1.08
A highly divergent retroviral sequence in the tuatara (Sphenodon). Virology (1995) 1.08
Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor. J Thromb Haemost (2010) 1.07
The location of the active site of blood coagulation factor VIIa above the membrane surface and its reorientation upon association with tissue factor. A fluorescence energy transfer study. J Biol Chem (1996) 1.06
Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin gene. Proc Natl Acad Sci U S A (1990) 1.02
Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci U S A (1990) 1.02
Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem (1996) 1.01
The timing of cell-type-specific differentiation in Dictyostelium discoideum. Dev Biol (1984) 1.01
Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. J Thromb Haemost (2013) 0.99
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost (1994) 0.98
What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? J Thromb Haemost (2010) 0.98
Tissue factor localization in non-human primate cerebral tissue. Thromb Haemost (1992) 0.96
Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity. Thromb Haemost (1993) 0.95
Haemostatic factors in human peripheral afferent lymph. Thromb Haemost (2000) 0.94
Pattern formation in Dictyostelium discoideum: an analysis of mutants altered in cell proportioning. Dev Biol (1981) 0.93
Analysis of the functions of the first epidermal growth factor-like domain of factor X. J Biol Chem (1993) 0.93
Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry (1996) 0.92
Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation (2000) 0.91
Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J Biol Chem (1992) 0.91
Cleavage of the thrombin receptor: identification of potential activators and inactivators. Biochem J (1996) 0.91
The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem (1994) 0.90
Factor XI anion-binding sites are required for productive interactions with polyphosphate. J Thromb Haemost (2013) 0.90
Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: importance of amino acid residue K192. Biochemistry (1995) 0.90
Tissue factor regulation and gene organization. Oxf Surv Eukaryot Genes (1989) 0.90
Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J Biol Chem (1999) 0.87
Differentiation-related death of an established keratinocyte line in suspension culture. J Cell Physiol (1978) 0.87
Effect of treatment with low-dose warfarin-aspirin on activated factor VII. Blood (1995) 0.86
An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates. Blood (1992) 0.86
Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis. Mult Scler (2002) 0.83
Tissue factor expression in mesothelial cells: induction both in vivo and in vitro. Am J Respir Cell Mol Biol (1997) 0.83
Tissue factor contributes to microvascular defects after focal cerebral ischemia. Stroke (1993) 0.82
Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost (2010) 0.82
RT-PCR microlocalization of mRNAs for calbindin D28k and vitamin D receptor in the murine nephron. Am J Physiol (1996) 0.82
Whole-blood platelet aggregation predicts in vitro and in vivo primary hemostatic function in the elderly. Arterioscler Thromb Vasc Biol (1995) 0.81
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem (1991) 0.81
The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost (2000) 0.81
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease. Scand Cardiovasc J (1998) 0.81
Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis. Biochemistry (1996) 0.81
Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C. Biochemistry (1999) 0.80
Dexamethasone enhances agonist induction of tissue factor in monocytes but not in endothelial cells. Blood Coagul Fibrinolysis (1993) 0.80
Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation. J Thromb Haemost (2012) 0.79
Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor. Biochemistry (1999) 0.79
Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin. J Thromb Haemost (2007) 0.79
Ultrasonically dense amniotic fluid in early pregnancy in asymptomatic women without vaginal bleeding. A report of two cases. J Reprod Med (1998) 0.79
A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin Immunol Immunopathol (1990) 0.78
Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII). Atherosclerosis (2000) 0.77
Monoclonal antibodies specific for stalk differentiation in Dictyostelium discoideum. Cell Differ (1984) 0.77
Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin. J Thromb Haemost (2006) 0.77
Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A. Haemophilia (2014) 0.77
Deficiency in homogentisic acid oxidase activity associated with the brown phenotype of Dictyostelium discoideum. J Gen Microbiol (1983) 0.77
Phospholipid composition controls thromboplastin sensitivity to individual clotting factors. J Thromb Haemost (2006) 0.76
Clotting dispute. Science (1996) 0.75
The ability of tissue factor to promote factor VII activation. Blood (1996) 0.75
Polycythaemia and microcytosis arising from the combination of a new high oxygen affinity haemoglobin (Hb luton, alpha 89 His-->Leu) and alpha thalassaemia trait. Br J Haematol (1992) 0.75
Clotting dispute. Science (1996) 0.75
Activated factor VII levels in patients with angiographically confirmed coronary artery disease. Am J Cardiol (1997) 0.75
Amputation at the Hip-Joint. Br Med J (1889) 0.75
Steady state levels of factor X mRNA in liver and Hep G2 cells. Blood (1987) 0.75
Chorioamnionitis does not affect fetal urine production in patients with premature rupture of membranes. J Matern Fetal Med (1997) 0.75
Two signals to shape a slime mould. Nature (1983) 0.75
Factor VII activation, apolipoprotein A-I and reverse cholesterol transport: possible relevance for postprandial lipaemia. Thromb Haemost (2002) 0.75
DNA analysis using polymerase chain reactions in the families of children with cystic fibrosis. N Z Med J (1990) 0.75
Factor V Leiden mutation in one family of Chinese origin. Chin Med J (Engl) (2001) 0.75